EP2819667

RETINAL DERIVATIVES FOR USE IN IMPROVING VISUAL FUNCTION

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    1.3.2013
  • EP published:
    25.12.2019
  • EP application number:
    13760943.4
  • Max expiry date:
    28.2.2033
  • Title:
    RETINAL DERIVATIVES FOR USE IN IMPROVING VISUAL FUNCTION

Timeline

Today
1.3.2013EP application
25.12.2019EP Publication

Owner

  • Name:
    Retinagenix Therapeutics, Inc.
  • Address:
    421 Kipling Street, Palo Alto, California 94301, US

Inventor

  • Name:
    CADDEN, Suzanne
  • Address:
    North Vancouver, British Columbia V7R 3Y7, CA

Priority

  • Number:
    201261605729 P
  • Date:
    1.3.2012
  • Country:
    US
  • Number:
    201261642212 P
  • Date:
    3.5.2012
  • Country:
    US
  • Number:
    201261644360 P
  • Date:
    8.5.2012
  • Country:
    US

Classification

  • Categories:
    A61K 31/232, A61P 27/02

Upload documents